BackgroundPrimary liver cancer is one of the most common malignancies in theworld,and for patients with hepatocellular carcinoma (HCC) the most maintreatment is radical resection. The metastasis after resection is stillat a loss what to do because the recurrence rate is as high as70%aftermetastasis,and survival rate is only17%~53%.So looking for new ways tosolve this problem has become a burning issue.MicroRNA (miRNA) is a kindof single non coding RNA with the length about21-26bp, it participatesin a variety of life activities through influencing a target gene and itsrelated products expression level.Many different microRNAs has beenrecognized relevant to the tumorigenesis and metastasis.A recent studyhas found that the expression level of microRNA-10b (miRNA-10b, miR–10b)in liver cancer tissue is higher than that in the normal tissue,whichsuggests that miR-10b may play a role in the occurrence and developmentof liver cancer. This paper mainly discusses the influence of miR-10b oninvasion and metastasis in liver cancer cell.ObjectivesEvaluate the effect of miR-10b gene on the invasion and metastasisability of human liver cancer cell line HepG2.MethodsTransfect the recombinant eukaryotic expression plasmid vector withmiR-10b the sequence and antisense is into HepG2with lipofectane.detecte the instant transfection efficiency through the fluorescence microscope(quantitative or qualitative) and using real-time PCR.And then test thedifference of migration,invasion ability and targeting proteinexpression between the groups by Western blotting and Matrigel InvasionAssay.Results1.Expression of the miR-10b has increased after the transfection ofthe sequence vector according to real-time PCR。2. Expression of the sequence miR-10b promotes the invasion andmetastasis ability of human liver cancer cell lines,induces PPAR-a,MMP-9expression,decreases E-cad expression in vitro.3.Transfecting the antisense recombinant vector has the converseeffection。ConclusionMiR-10b gene has the effect on the invasion and metastasis abilityof human liver cancer cell line HepG2. |